Outlining the most important sustainability-related hurdles facing leading biopharma companies today—and current efforts underway to meet new expectations in advancing this strategic mandate.
Meaningful biopharma sustainability metrics are a crucial challenge.
Biopharma sustainability resolutions for a better 2021.
Why major companies are stepping up environmental commitments.
SynBio opens new environmental sustainability possibilities for pharma.
Biopharma must find sustainable models for public policy engagement.